메뉴 건너뛰기




Volumn 121, Issue 15, 2003, Pages 583-587

Atheroma plaque stabilization: A new concept based on the dynamic biology of atherosclerosis;Estabilización de la placa de ateroma: Un nuevo concepto basado en la biología dinámica de la aterosclerosis

Author keywords

Anti atherosclerotic strategies; Atherosclerosis; Non invasive assessment of atherosclerosis; Plaque stabilization

Indexed keywords

ANTICOAGULANT AGENT; ANTIOXIDANT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ESTROGEN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

EID: 0345708298     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1157/13053808     Document Type: Review
Times cited : (9)

References (75)
  • 1
    • 0033552883 scopus 로고    scopus 로고
    • Atherosclerosis. An inflammatory disease
    • Ross R. Atherosclerosis. An inflammatory disease. N Engl J Med 1999;340:115-26.
    • (1999) N Engl J Med , vol.340 , pp. 115-126
    • Ross, R.1
  • 2
    • 0037180771 scopus 로고    scopus 로고
    • Inflammation in atherosclerosis
    • Libby P. Inflammation in atherosclerosis. Nature 2002;420:868-74.
    • (2002) Nature , vol.420 , pp. 868-874
    • Libby, P.1
  • 5
    • 0037847632 scopus 로고    scopus 로고
    • Is there a vulnerable plaque?
    • Maseri A, Fuster V. Is there a vulnerable plaque? Circulation 2003;107: 2068-71.
    • (2003) Circulation , vol.107 , pp. 2068-2071
    • Maseri, A.1    Fuster, V.2
  • 6
    • 0003748859 scopus 로고    scopus 로고
    • Reversibilidad de la función endotelial y cambios hemostáticos en la prevención y tratamiento de la aterosclerosis
    • Páramo JA, Orbe J. Reversibilidad de la función endotelial y cambios hemostáticos en la prevención y tratamiento de la aterosclerosis. Rev Iberoam Trombosis y Hemostasia 1999;12:167-72.
    • (1999) Rev Iberoam Trombosis y Hemostasia , vol.12 , pp. 167-172
    • Páramo, J.A.1    Orbe, J.2
  • 8
    • 0029891485 scopus 로고    scopus 로고
    • Contribution of inadequate compensatory enlargement to development of human coronary artery stenosis: An in vivo intravascular ultrasound study
    • Nishioka T, Luo H, Eigler NL, Berglund H, Kim CJ, Siegel RJ. Contribution of inadequate compensatory enlargement to development of human coronary artery stenosis: an in vivo intravascular ultrasound study. J Am Coll Cardiol 1996;27:1571-6.
    • (1996) J Am Coll Cardiol , vol.27 , pp. 1571-1576
    • Nishioka, T.1    Luo, H.2    Eigler, N.L.3    Berglund, H.4    Kim, C.J.5    Siegel, R.J.6
  • 9
    • 0026524594 scopus 로고
    • Relation of the site of acute myocardial infarction to the most severe coronary arterial stenosis at prior angiography
    • Giroud D, Li JM, Urban P, Meier B, Rutishauer W. Relation of the site of acute myocardial infarction to the most severe coronary arterial stenosis at prior angiography. Am J Cardiol 1992;69:729-32.
    • (1992) Am J Cardiol , vol.69 , pp. 729-732
    • Giroud, D.1    Li, J.M.2    Urban, P.3    Meier, B.4    Rutishauer, W.5
  • 10
    • 0035970098 scopus 로고    scopus 로고
    • Intravascular ultrasound: Novel pathophysiological insights and current clinical applications
    • Nissen SE, Yock P. Intravascular ultrasound: novel pathophysiological insights and current clinical applications. Circulation 2001;103:604-16.
    • (2001) Circulation , vol.103 , pp. 604-616
    • Nissen, S.E.1    Yock, P.2
  • 11
    • 0034602617 scopus 로고    scopus 로고
    • Prevention Conference V: Beyond secondary prevention: Identifying the high-risk patient for primary prevention: Noninvasive tests of atherosclerotic burden: Writing Group III
    • Greenland P, Abrams J, Aurigemma GP, Bond MG, Clark LT, Criqui MH, et al. Prevention Conference V: beyond secondary prevention: identifying the high-risk patient for primary prevention: noninvasive tests of atherosclerotic burden: Writing Group III. Circulation 2000;101:E16-22.
    • (2000) Circulation , vol.101
    • Greenland, P.1    Abrams, J.2    Aurigemma, G.P.3    Bond, M.G.4    Clark, L.T.5    Criqui, M.H.6
  • 12
    • 0032519844 scopus 로고    scopus 로고
    • The role of carotid arterial intima-media thickness in predicting clinical coronary events
    • Hodis HN, Mack WJ, LaBree L, Selzer RH, Liu CR, Liu CH, et al. The role of carotid arterial intima-media thickness in predicting clinical coronary events. Ann Intern Med 1998;128:262-9.
    • (1998) Ann Intern Med , vol.128 , pp. 262-269
    • Hodis, H.N.1    Mack, W.J.2    LaBree, L.3    Selzer, R.H.4    Liu, C.R.5    Liu, C.H.6
  • 13
    • 0027156348 scopus 로고
    • Beneficial effects of colestipol-niacin therapy on the common carotid artery. Two- and four-year reduction of intima-media thickness measured by ultrasound
    • Blankenhorn DH, Selzer RH, Crawford DW, Barth JD, Liu CR, Liu CH, et al. Beneficial effects of colestipol-niacin therapy on the common carotid artery. Two- and four-year reduction of intima-media thickness measured by ultrasound. Circulation 1993;88:20-8.
    • (1993) Circulation , vol.88 , pp. 20-28
    • Blankenhorn, D.H.1    Selzer, R.H.2    Crawford, D.W.3    Barth, J.D.4    Liu, C.R.5    Liu, C.H.6
  • 14
    • 0030848434 scopus 로고    scopus 로고
    • Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: The Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993
    • Chambles LE, Heiss G, Folsom AR, Rosamond W, Szklo M, Sharrett AR, et al. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. Am J Epidemiol 1997;146:483-94.
    • (1997) Am J Epidemiol , vol.146 , pp. 483-494
    • Chambles, L.E.1    Heiss, G.2    Folsom, A.R.3    Rosamond, W.4    Szklo, M.5    Sharrett, A.R.6
  • 15
    • 0033531215 scopus 로고    scopus 로고
    • Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults
    • Cardiovascular Health Study Collaborative Research Group
    • O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 1999;340:14-22.
    • (1999) N Engl J Med , vol.340 , pp. 14-22
    • O'Leary, D.H.1    Polak, J.F.2    Kronmal, R.A.3    Manolio, T.A.4    Burke, G.L.5    Wolfson Jr., S.K.6
  • 16
    • 10744232398 scopus 로고    scopus 로고
    • Independent association of fibrinogen with carotid intima-media thickness in asymptomatic subjects
    • Martínez-Vila E, Páramo JA, Beloqui O, Orbe J, Irimia P, Colina I, et al. Independent association of fibrinogen with carotid intima-media thickness in asymptomatic subjects. Cerebrovasc Dis 2003;16:356-62.
    • (2003) Cerebrovasc Dis , vol.16 , pp. 356-362
    • Martínez-Vila, E.1    Páramo, J.A.2    Beloqui, O.3    Orbe, J.4    Irimia, P.5    Colina, I.6
  • 17
    • 0034655524 scopus 로고    scopus 로고
    • Prognostic value of coronary electron-beam computed tomography for coronary heart disease events in asymptomatic populations
    • O'Malley PG, Taylor AJ, Jackson JL, Doherty TM, Detrano RC. Prognostic value of coronary electron-beam computed tomography for coronary heart disease events in asymptomatic populations. Am J Cardiol 2000;85:945-8.
    • (2000) Am J Cardiol , vol.85 , pp. 945-948
    • O'Malley, P.G.1    Taylor, A.J.2    Jackson, J.L.3    Doherty, T.M.4    Detrano, R.C.5
  • 18
    • 0033602810 scopus 로고    scopus 로고
    • Coronary calcium does not accurately predict near-term future coronary events in high-risk adults
    • Detrano RC, Wong ND, Doherty TM, Shavelle RM, Tang W, Ginzton LE, et al. Coronary calcium does not accurately predict near-term future coronary events in high-risk adults. Circulation 1999;99:2633-8.
    • (1999) Circulation , vol.99 , pp. 2633-2638
    • Detrano, R.C.1    Wong, N.D.2    Doherty, T.M.3    Shavelle, R.M.4    Tang, W.5    Ginzton, L.E.6
  • 19
    • 0033993755 scopus 로고    scopus 로고
    • Identification of patients at increased risk of first unheralded acute myocardial infarction by electron-beam computed tomography
    • Raggi P, Callister TQ, Cooil B, He ZX, Lippolis NJ, Russo DJ, et al. Identification of patients at increased risk of first unheralded acute myocardial infarction by electron-beam computed tomography. Circulation 2000; 101:850-5.
    • (2000) Circulation , vol.101 , pp. 850-855
    • Raggi, P.1    Callister, T.Q.2    Cooil, B.3    He, Z.X.4    Lippolis, N.J.5    Russo, D.J.6
  • 20
    • 0034074888 scopus 로고    scopus 로고
    • High resolution ex vivo magnetic resonance imaging of in situ coronary and aortic atherosclerotic plaque in a porcine model
    • Worthley SG, Helft G, Fuster V, Fayad ZA, Fallon JT, Osende JI, et al. High resolution ex vivo magnetic resonance imaging of in situ coronary and aortic atherosclerotic plaque in a porcine model. Atherosclerosis 2000; 150:321-9.
    • (2000) Atherosclerosis , vol.150 , pp. 321-329
    • Worthley, S.G.1    Helft, G.2    Fuster, V.3    Fayad, Z.A.4    Fallon, J.T.5    Osende, J.I.6
  • 21
    • 0034255293 scopus 로고    scopus 로고
    • Noninvasive in vivo human coronary artery lumen and wall imaging using black-blood magnetic resonance imaging
    • Fayad ZA, Fuster V, Fallon JT, Jayaundera T, Worthley SG, Helft G, et al Noninvasive in vivo human coronary artery lumen and wall imaging using black-blood magnetic resonance imaging. Circulation 2000;102: 506-10.
    • (2000) Circulation , vol.102 , pp. 506-510
    • Fayad, Z.A.1    Fuster, V.2    Fallon, J.T.3    Jayaundera, T.4    Worthley, S.G.5    Helft, G.6
  • 22
    • 0037176939 scopus 로고    scopus 로고
    • Progression and regression of atherosclerotic lesions: Monitoring with serial noninvasive magnetic resonance imaging
    • Helft G, Worthley SG, Fuster V, Fayad ZA, Zaman A, Corti R, et al. Progression and regression of atherosclerotic lesions: monitoring with serial noninvasive magnetic resonance imaging. Circulation 2002; 105:993-8.
    • (2002) Circulation , vol.105 , pp. 993-998
    • Helft, G.1    Worthley, S.G.2    Fuster, V.3    Fayad, Z.A.4    Zaman, A.5    Corti, R.6
  • 23
    • 0035902442 scopus 로고    scopus 로고
    • Effects of lipid-lowering by simvastatin on human atherosclerotic lesions: A longitudinal study by high-resolution, noninvasive magnetic resonance imaging
    • Corti R, Fayad ZA, Fuster V, Worthley SG, Helft G, Chesebro J, et al. Effects of lipid-lowering by simvastatin on human atherosclerotic lesions: a longitudinal study by high-resolution, noninvasive magnetic resonance imaging. Circulation 2001;104:249-52.
    • (2001) Circulation , vol.104 , pp. 249-252
    • Corti, R.1    Fayad, Z.A.2    Fuster, V.3    Worthley, S.G.4    Helft, G.5    Chesebro, J.6
  • 24
    • 0032572043 scopus 로고    scopus 로고
    • Antiatherothrombotic properties of statins: Implications for cardiovascular event reduction
    • Rosenson RS, Tangney CC. Antiatherothrombotic properties of statins: implications for cardiovascular event reduction. JAMA 1998;279:1643-50.
    • (1998) JAMA , vol.279 , pp. 1643-1650
    • Rosenson, R.S.1    Tangney, C.C.2
  • 26
    • 0027987849 scopus 로고
    • Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
    • The Scandinavian Simvastatin Survival Study (4S) Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344: 1383-9.
    • (1994) Lancet , vol.344 , pp. 1383-1389
  • 27
    • 0342981862 scopus 로고    scopus 로고
    • The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
    • Cholesterol and Recurrent Events Trial investigators
    • Sacks FM, Pfeffer MA, Moye LA, Rouleau JL, Rutherford JD, Cole TG, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med 1996;335:1001-9.
    • (1996) N Engl J Med , vol.335 , pp. 1001-1009
    • Sacks, F.M.1    Pfeffer, M.A.2    Moye, L.A.3    Rouleau, J.L.4    Rutherford, J.D.5    Cole, T.G.6
  • 28
    • 0028883828 scopus 로고
    • Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia
    • West of Scotland Coronary Prevention Study Group
    • Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, McFarlane PW, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med 1995;333:1301-7.
    • (1995) N Engl J Med , vol.333 , pp. 1301-1307
    • Shepherd, J.1    Cobbe, S.M.2    Ford, I.3    Isles, C.G.4    Lorimer, A.R.5    McFarlane, P.W.6
  • 29
    • 0032487931 scopus 로고    scopus 로고
    • Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
    • The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med 1998;339:1349-57.
    • (1998) N Engl J Med , vol.339 , pp. 1349-1357
  • 30
    • 0032572086 scopus 로고    scopus 로고
    • Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: Results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study
    • Downs JR, Clearfield M, Weis S, Whitney E, Shapiro DR, Beere PA, et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA 1998; 279:1615-22.
    • (1998) JAMA , vol.279 , pp. 1615-1622
    • Downs, J.R.1    Clearfield, M.2    Weis, S.3    Whitney, E.4    Shapiro, D.R.5    Beere, P.A.6
  • 31
    • 0037109137 scopus 로고    scopus 로고
    • ARBITER: Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol: A randomized trial comparing the effects of atorvastatin and pravastatin on carotid intima medial thickness
    • Taylor AJ, Kent SM, Flaherty PJ, Coyle LC, Markwood TT, Vernalis MN. ARBITER: Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol: a randomized trial comparing the effects of atorvastatin and pravastatin on carotid intima medial thickness. Circulation 2002;106:2055-60.
    • (2002) Circulation , vol.106 , pp. 2055-2060
    • Taylor, A.J.1    Kent, S.M.2    Flaherty, P.J.3    Coyle, L.C.4    Markwood, T.T.5    Vernalis, M.N.6
  • 32
    • 0035943069 scopus 로고    scopus 로고
    • Use of intravascular ultrasound to compare effects of different strategies of lipid-lowering therapy on plaque volume and composition in patients with coronary artery disease
    • Schartl M, Bocksh W, Koschyk DH, Voelker W, Karsch KR, Kreuzer J, et al. Use of intravascular ultrasound to compare effects of different strategies of lipid-lowering therapy on plaque volume and composition in patients with coronary artery disease. Circulation 2001;104:387-92.
    • (2001) Circulation , vol.104 , pp. 387-392
    • Schartl, M.1    Bocksh, W.2    Koschyk, D.H.3    Voelker, W.4    Karsch, K.R.5    Kreuzer, J.6
  • 33
    • 0037016049 scopus 로고    scopus 로고
    • Lipid lowering by simvastatin induces regression of human atherosclerotic lesions: Two years' follow-up by high-resolution noninvasive magnetic resonance imaging
    • Corti R, Fuster V, Fayad ZA, Worthley SG, Helft G, Smith D, et al. Lipid lowering by simvastatin induces regression of human atherosclerotic lesions: two years' follow-up by high-resolution noninvasive magnetic resonance imaging. Circulation 2002;106:2884-7.
    • (2002) Circulation , vol.106 , pp. 2884-2887
    • Corti, R.1    Fuster, V.2    Fayad, Z.A.3    Worthley, S.G.4    Helft, G.5    Smith, D.6
  • 34
    • 0037420492 scopus 로고    scopus 로고
    • Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower than average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): A multicentre randomized controlled trial
    • Sever PS, Dahlof B, Poulter NR, Wedel H, Beevers G, Caulfield M, et al. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower than average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): a multicentre randomized controlled trial. Lancet 2003;361:1149-58.
    • (2003) Lancet , vol.361 , pp. 1149-1158
    • Sever, P.S.1    Dahlof, B.2    Poulter, N.R.3    Wedel, H.4    Beevers, G.5    Caulfield, M.6
  • 35
    • 0037167661 scopus 로고    scopus 로고
    • Effects of atorvastatin on stroke in patients with unstable angina or non-Q-wave myocardial infarction: A Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) substudy
    • Waters DD, Schwartz GG, Olsson AG, Zeiher A, Oliver MF, Ganz P, et al. Effects of atorvastatin on stroke in patients with unstable angina or non-Q-wave myocardial infarction: a Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) substudy. Circulation 2002; 106:1690-5.
    • (2002) Circulation , vol.106 , pp. 1690-1695
    • Waters, D.D.1    Schwartz, G.G.2    Olsson, A.G.3    Zeiher, A.4    Oliver, M.F.5    Ganz, P.6
  • 36
    • 0037031061 scopus 로고    scopus 로고
    • MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: A randomised placebo-controlled trial
    • Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002;360:7-22.
    • (2002) Lancet , vol.360 , pp. 7-22
  • 37
    • 0032554676 scopus 로고    scopus 로고
    • Influence of pravastatin and plasma lipids on clinical events in the West of Scotland Coronary Prevention Study (WOSCOPS)
    • West of Scotland Coronary Prevention Study Group. Influence of pravastatin and plasma lipids on clinical events in the West of Scotland Coronary Prevention Study (WOSCOPS). Circulation 1998;97:1440-5.
    • (1998) Circulation , vol.97 , pp. 1440-1445
  • 38
    • 0032554688 scopus 로고    scopus 로고
    • Relationship between plasma LDL concentrations during treatment with pravastatin and recurrent coronary events in the Cholesterol and Recurrent Events trial
    • Sacks FM, Moye LA, Davis BR, Cole TG, Rouleau JL, Nash DT, et al. Relationship between plasma LDL concentrations during treatment with pravastatin and recurrent coronary events in the Cholesterol and Recurrent Events trial. Circulation 1998;97:1446-52.
    • (1998) Circulation , vol.97 , pp. 1446-1452
    • Sacks, F.M.1    Moye, L.A.2    Davis, B.R.3    Cole, T.G.4    Rouleau, J.L.5    Nash, D.T.6
  • 39
    • 0033862040 scopus 로고    scopus 로고
    • Atorvastatin but not L-arginine improves endothelial function in type I diabetes mellitus: A double-blind study
    • Mullen MJ, Wright D, Donald AE, Thorne S, Thomson H, Deanfield JE. Atorvastatin but not L-arginine improves endothelial function in type I diabetes mellitus: a double-blind study. J Am Coll Cardiol 2000;36:410-6.
    • (2000) J Am Coll Cardiol , vol.36 , pp. 410-416
    • Mullen, M.J.1    Wright, D.2    Donald, A.E.3    Thorne, S.4    Thomson, H.5    Deanfield, J.E.6
  • 40
    • 0035901619 scopus 로고    scopus 로고
    • Effect of hydroxymethyl glutaryl coenzyme a reductase inhibitor therapy on high sensitive C-reactive protein levels
    • Jialat I, Stein D, Balis D, Grundy SM, Adams-Huet B, Devaraj S. Effect of hydroxymethyl glutaryl coenzyme a reductase inhibitor therapy on high sensitive C-reactive protein levels Circulation 2001;103:1933-5.
    • (2001) Circulation , vol.103 , pp. 1933-1935
    • Jialat, I.1    Stein, D.2    Balis, D.3    Grundy, S.M.4    Adams-Huet, B.5    Devaraj, S.6
  • 41
    • 0033918074 scopus 로고    scopus 로고
    • Pravastatin attenuates cardiovascular inflammatory and proliferative changes in a rat model of chronic inhibition of nitric oxide synthesis by its cholesterol-lowering Independent actions
    • Egashira K, Ni W, Inoue S, Kataoka C, Kitamoto S, Koyanagi M, et al. Pravastatin attenuates cardiovascular inflammatory and proliferative changes in a rat model of chronic inhibition of nitric oxide synthesis by its cholesterol-lowering Independent actions. Hypertens Res 2000; 23:353-8.
    • (2000) Hypertens Res , vol.23 , pp. 353-358
    • Egashira, K.1    Ni, W.2    Inoue, S.3    Kataoka, C.4    Kitamoto, S.5    Koyanagi, M.6
  • 42
    • 0343048978 scopus 로고    scopus 로고
    • Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation
    • Wagner AH, Kohler T, Ruckschloss U, Just I, Hecker M. Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation. Arterioscler Thromb Vasc Biol 2000;20:61-9.
    • (2000) Arterioscler Thromb Vasc Biol , vol.20 , pp. 61-69
    • Wagner, A.H.1    Kohler, T.2    Ruckschloss, U.3    Just, I.4    Hecker, M.5
  • 43
    • 0035569562 scopus 로고    scopus 로고
    • HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species
    • Wassmann S, Laufs U, Baumer AT, Muller K, Ahlbory K, Linz W, et al. HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species. Hypertension 2001;37:1450-7.
    • (2001) Hypertension , vol.37 , pp. 1450-1457
    • Wassmann, S.1    Laufs, U.2    Baumer, A.T.3    Muller, K.4    Ahlbory, K.5    Linz, W.6
  • 44
    • 0035912855 scopus 로고    scopus 로고
    • Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease
    • Vasa M, Flchtlscherer S, Adler K, Aicher A, Martin H, Zeiher AM, et al. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation 2001;103:2885-90.
    • (2001) Circulation , vol.103 , pp. 2885-2890
    • Vasa, M.1    Flchtlscherer, S.2    Adler, K.3    Aicher, A.4    Martin, H.5    Zeiher, A.M.6
  • 45
    • 0034898468 scopus 로고    scopus 로고
    • HMG-CoA reductase inhibitor mobilizes bone marrow-derived endothelial progenitor cells
    • Llevadot J, Murasawa K, Kureishi Y, Uchida S, Masuda H, Kawamoto A, et al. HMG-CoA reductase inhibitor mobilizes bone marrow-derived endothelial progenitor cells. J Clin Invest 2001;108:399-405.
    • (2001) J Clin Invest , vol.108 , pp. 399-405
    • Llevadot, J.1    Murasawa, K.2    Kureishi, Y.3    Uchida, S.4    Masuda, H.5    Kawamoto, A.6
  • 46
    • 0028125199 scopus 로고
    • Antiatherogenic effects of beta-adrenergic blocking agents: Theoretical, experimental, and epidemiologic considerations
    • Kaplan JR, Manuck SB. Antiatherogenic effects of beta-adrenergic blocking agents: theoretical, experimental, and epidemiologic considerations. Am Heart J 1994;128:1316-28.
    • (1994) Am Heart J , vol.128 , pp. 1316-1328
    • Kaplan, J.R.1    Manuck, S.B.2
  • 47
    • 0023279471 scopus 로고
    • The effects of beta-adrenergic blocking agents on atherosclerosis and its complications
    • Kaplan JR, Manuck SB, Adas MR, Clarkson TB. The effects of beta-adrenergic blocking agents on atherosclerosis and its complications. Eur Heart J 1987;8:928-44.
    • (1987) Eur Heart J , vol.8 , pp. 928-944
    • Kaplan, J.R.1    Manuck, S.B.2    Adas, M.R.3    Clarkson, T.B.4
  • 48
    • 0035799330 scopus 로고    scopus 로고
    • Low-dose metoprolol CR/XL and fluvastatin slow progression of carotid intima-media thickness: Main results from the Beta-Blocker Cholesterol-Lowering Asymptomatic Plaque Study (BCAPS)
    • Hedblad B, Wikstrand J, Janzon L, Wedel H, Berglund G. Low-dose metoprolol CR/XL and fluvastatin slow progression of carotid intima-media thickness: main results from the Beta-Blocker Cholesterol-Lowering Asymptomatic Plaque Study (BCAPS). Circulation 2001;103:1721-6.
    • (2001) Circulation , vol.103 , pp. 1721-1726
    • Hedblad, B.1    Wikstrand, J.2    Janzon, L.3    Wedel, H.4    Berglund, G.5
  • 49
    • 0036158710 scopus 로고    scopus 로고
    • Effect of controlled release/extended release metoprolol on carotid intima-media thickness in patients with hypercholesterolemia: A 3-year randomized study
    • Wiklund O, Hulthe J, Wikstrans J, Schmidt C, Olopsson SO, Bodjers G. Effect of controlled release/extended release metoprolol on carotid intima-media thickness in patients with hypercholesterolemia: a 3-year randomized study. Stroke 2002;33:572-7.
    • (2002) Stroke , vol.33 , pp. 572-577
    • Wiklund, O.1    Hulthe, J.2    Wikstrans, J.3    Schmidt, C.4    Olopsson, S.O.5    Bodjers, G.6
  • 50
    • 0035810524 scopus 로고    scopus 로고
    • Papel de los antioxidantes en la prevención de la enfermedad cardiovascular
    • Páramo JA, Orbe J, Rodríguez JA. Papel de los antioxidantes en la prevención de la enfermedad cardiovascular. Med Clin (Barc) 2001; 116:629-35.
    • (2001) Med Clin (Barc) , vol.116 , pp. 629-635
    • Páramo, J.A.1    Orbe, J.2    Rodríguez, J.A.3
  • 51
    • 0036839916 scopus 로고    scopus 로고
    • Dietary supplementation with vitamins C and E prevents down-regulation of endothelial NOS expression in hypercholesterolemia in vivo and in vitro
    • Rodríguez JA, Grau A, Eguinoa E, Nespereira B, Pérez-Ilzarbe M, Arias R, et al. Dietary supplementation with vitamins C and E prevents down-regulation of endothelial NOS expression in hypercholesterolemia in vivo and in vitro. Atherosclerosis 2002;165:33-40.
    • (2002) Atherosclerosis , vol.165 , pp. 33-40
    • Rodríguez, J.A.1    Grau, A.2    Eguinoa, E.3    Nespereira, B.4    Pérez-Ilzarbe, M.5    Arias, R.6
  • 52
    • 0037372961 scopus 로고    scopus 로고
    • Antioxidant vitamins increase the collagen content and reduce MMP-1 in a porcine model of atherosclerosis: Implications for plaque stabilization
    • Orbe J, Rodríguez JA, Arias R, Belzunce M, Nespereira B, Pérez-Ilzarbe M, et al. Antioxidant vitamins increase the collagen content and reduce MMP-1 in a porcine model of atherosclerosis: implications for plaque stabilization Atherosclerosis 2003;167:45-53.
    • (2003) Atherosclerosis , vol.167 , pp. 45-53
    • Orbe, J.1    Rodríguez, J.A.2    Arias, R.3    Belzunce, M.4    Nespereira, B.5    Pérez-Ilzarbe, M.6
  • 53
    • 0027275148 scopus 로고
    • Nutrition intervention trials in Linxian, China: Supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population
    • Blot WJ, Li JY, Taylor PR, Guo W, Dawsey S, Wang GQ, et al. Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J Natl Cancer Inst 1993;85:1483-92.
    • (1993) J Natl Cancer Inst , vol.85 , pp. 1483-1492
    • Blot, W.J.1    Li, J.Y.2    Taylor, P.R.3    Guo, W.4    Dawsey, S.5    Wang, G.Q.6
  • 54
    • 0010607277 scopus 로고
    • The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers
    • The Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994;330:1029-35.
    • (1994) N Engl J Med , vol.330 , pp. 1029-1035
  • 55
    • 0029925181 scopus 로고    scopus 로고
    • Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS)
    • Stephens NG. Parsons A, Schofield PM, Kelly F, Cheeseman K, Mitchinson MJ. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 1996;347:781-6.
    • (1996) Lancet , vol.347 , pp. 781-786
    • Stephens, N.G.1    Parsons, A.2    Schofield, P.M.3    Kelly, F.4    Cheeseman, K.5    Mitchinson, M.J.6
  • 56
    • 0345109256 scopus 로고    scopus 로고
    • Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: Results of the GISSI-Prevenzione trial
    • Grupo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 1999;354:447-55.
    • (1999) Lancet , vol.354 , pp. 447-455
  • 57
    • 0034724305 scopus 로고    scopus 로고
    • Expression of angiotensin N and interleukin 6 in human coronary atherosclerotic plaques: Potential implications for inflammation and plaque instability
    • Schieffer B, Schieffer E, Hilfiker-Kleiner D, Hilfiker A, Kovanen PT, Kaartinen M, et al. Expression of angiotensin N and interleukin 6 in human coronary atherosclerotic plaques: potential implications for inflammation and plaque instability. Circulation 2000;101:1372-8.
    • (2000) Circulation , vol.101 , pp. 1372-1378
    • Schieffer, B.1    Schieffer, E.2    Hilfiker-Kleiner, D.3    Hilfiker, A.4    Kovanen, P.T.5    Kaartinen, M.6
  • 58
    • 0035916235 scopus 로고    scopus 로고
    • Effects of ramipril and vitamin E on atherosclerosis: The study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE)
    • Lonn E, Yusuf S, Dzavik V, Doris C, Yi Q, Smith S, et al. Effects of ramipril and vitamin E on atherosclerosis: the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE). Circulation 2001;103:919-25.
    • (2001) Circulation , vol.103 , pp. 919-925
    • Lonn, E.1    Yusuf, S.2    Dzavik, V.3    Doris, C.4    Yi, Q.5    Smith, S.6
  • 59
    • 0034688194 scopus 로고    scopus 로고
    • Effects of an angiotensin-converting enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients
    • The Heart Outcomes Prevention Evaluation (HOPE) Study Investigators. Effects of an angiotensin-converting enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 2000;342:145-53.
    • (2000) N Engl J Med , vol.342 , pp. 145-153
  • 60
    • 9444280103 scopus 로고    scopus 로고
    • Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing Endothelial Dysfunction) Study
    • Mancini GB, Henry GC, Macaya C, O'Neill BJ, Pucillo AL, Carere RG, et al. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing Endothelial Dysfunction) Study. Circulation 1996;94:258-65.
    • (1996) Circulation , vol.94 , pp. 258-265
    • Mancini, G.B.1    Henry, G.C.2    Macaya, C.3    O'Neill, B.J.4    Pucillo, A.L.5    Carere, R.G.6
  • 61
    • 0034718574 scopus 로고    scopus 로고
    • Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events
    • PREVENT Investigators
    • Pitt B, Byington RP, Furberg CD, Hunninghake DB, Mancini GB, Miller ME, et al. Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events. PREVENT Investigators. Circulation 2000;102:1503-10
    • (2000) Circulation , vol.102 , pp. 1503-1510
    • Pitt, B.1    Byington, R.P.2    Furberg, C.D.3    Hunninghake, D.B.4    Mancini, G.B.5    Miller, M.E.6
  • 62
    • 0034162202 scopus 로고    scopus 로고
    • Restenosis and clinical outcome in patients treated with amlodipine after angioplasty: Results from the Coronary AngioPlasty Amlodipine RES-tenosis Study (CAPARES)
    • Jorgensen B, Simonsen S, Endresen K, Forfang K, Vatne K, Hansen J, et al. Restenosis and clinical outcome in patients treated with amlodipine after angioplasty: results from the Coronary AngioPlasty Amlodipine RES-tenosis Study (CAPARES). J Am Coll Cardiol 2000;35:592-9.
    • (2000) J Am Coll Cardiol , vol.35 , pp. 592-599
    • Jorgensen, B.1    Simonsen, S.2    Endresen, K.3    Forfang, K.4    Vatne, K.5    Hansen, J.6
  • 63
    • 0037027501 scopus 로고    scopus 로고
    • Calcium antagonist lacidipine slows down progression of asymptomatic carotid atherosclerosis: Principal results of the European Lacidipine Study on Atherosclerosis (ELSA), a randomized, double-blind, long-term trial
    • Zanchetti A, Bond MG, Hennig M, Neiss A, Mancia G, Dal Palu C, et al. Calcium antagonist lacidipine slows down progression of asymptomatic carotid atherosclerosis: principal results of the European Lacidipine Study on Atherosclerosis (ELSA), a randomized, double-blind, long-term trial. Circulation 2002;106:2422-7.
    • (2002) Circulation , vol.106 , pp. 2422-2427
    • Zanchetti, A.1    Bond, M.G.2    Hennig, M.3    Neiss, A.4    Mancia, G.5    Dal Palu, C.6
  • 64
    • 0032513878 scopus 로고    scopus 로고
    • Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial
    • HOT Study Group
    • Hansson L, Zanchetti A, Carruthers SG, Dahlof B, Elmfeldt D, Julius S, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet 1998;351: 1755-62.
    • (1998) Lancet , vol.351 , pp. 1755-1762
    • Hansson, L.1    Zanchetti, A.2    Carruthers, S.G.3    Dahlof, B.4    Elmfeldt, D.5    Julius, S.6
  • 65
    • 0343487983 scopus 로고    scopus 로고
    • Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension
    • The Systolic Hypertension in Europe (SYST-EUR) Trial Investigators
    • Staessen JA, Fagard R, Thijs L, Celis H, Arabidze GG, Birkenhager WH, et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (SYST-EUR) Trial Investigators. Lancet 1997;350: 757-64.
    • (1997) Lancet , vol.350 , pp. 757-764
    • Staessen, J.A.1    Fagard, R.2    Thijs, L.3    Celis, H.4    Arabidze, G.G.5    Birkenhager, W.H.6
  • 66
    • 0028204074 scopus 로고
    • Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of premenopausal women
    • Losordo DW, Kearney M, Kim EA, Jekanowski J, Isner JM. Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of premenopausal women. Circulation 1994;89:1501-10.
    • (1994) Circulation , vol.89 , pp. 1501-1510
    • Losordo, D.W.1    Kearney, M.2    Kim, E.A.3    Jekanowski, J.4    Isner, J.M.5
  • 67
    • 0031866317 scopus 로고    scopus 로고
    • Hormone replacement therapy, heart disease, and other considerations
    • Barrett-Connor E, Grady D. Hormone replacement therapy, heart disease, and other considerations. Annu Rev Public Health 1998;19:55-72.
    • (1998) Annu Rev Public Health , vol.19 , pp. 55-72
    • Barrett-Connor, E.1    Grady, D.2
  • 68
    • 0030934673 scopus 로고    scopus 로고
    • Prevalence and determinants of carotid atherosclerosis in healthy postmenopausal women
    • Lassila HC, Tyrrell KS, Matthews KA, Wolfson SK, Kuller LH. Prevalence and determinants of carotid atherosclerosis in healthy postmenopausal women. Stroke 1997;28:513-7.
    • (1997) Stroke , vol.28 , pp. 513-517
    • Lassila, H.C.1    Tyrrell, K.S.2    Matthews, K.A.3    Wolfson, S.K.4    Kuller, L.H.5
  • 69
    • 0032547326 scopus 로고    scopus 로고
    • Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women
    • Heart and Estrogen/progestin Replacement Study (HERS) Research Group
    • Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group JAMA 1998;280: 605-13.
    • (1998) JAMA , vol.280 , pp. 605-613
    • Hulley, S.1    Grady, D.2    Bush, T.3    Furberg, C.4    Herrington, D.5    Riggs, B.6
  • 70
    • 0037125379 scopus 로고    scopus 로고
    • Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women
    • Women's Health Initiative Investigators. Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women. JAMA 2002;288: 321-33
    • (2002) JAMA , vol.288 , pp. 321-333
  • 71
    • 0034919319 scopus 로고    scopus 로고
    • Early risk of cardiovascular events after commencing hormone replacement therapy
    • Rossouw JE. Early risk of cardiovascular events after commencing hormone replacement therapy. Curr Opin Lipidol 2001;12:371-5.
    • (2001) Curr Opin Lipidol , vol.12 , pp. 371-375
    • Rossouw, J.E.1
  • 72
    • 0037145833 scopus 로고    scopus 로고
    • Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: A randomized controlled trial
    • Waters DD, Alderman EL, Hsia J, Howard BV, Cobb FR, Rogers WJ, et al. Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: a randomized controlled trial. JAMA 2002;288:2432-40.
    • (2002) JAMA , vol.288 , pp. 2432-2440
    • Waters, D.D.1    Alderman, E.L.2    Hsia, J.3    Howard, B.V.4    Cobb, F.R.5    Rogers, W.J.6
  • 73
    • 0035916902 scopus 로고    scopus 로고
    • Tamoxifen effects on endothelial function and cardiovascular risk factors in men with advanced atherosclerosis
    • Clarke SC, Schofield PM, Grace AA, Metcalfe JC, Krischenlohr HL. Tamoxifen effects on endothelial function and cardiovascular risk factors in men with advanced atherosclerosis. Circulation 2001;103:1497-502.
    • (2001) Circulation , vol.103 , pp. 1497-1502
    • Clarke, S.C.1    Schofield, P.M.2    Grace, A.A.3    Metcalfe, J.C.4    Krischenlohr, H.L.5
  • 75
    • 0037138787 scopus 로고    scopus 로고
    • Raloxifene and cardiovascular events in osteoporotic postmenopausal women: Four-year results from the MORE (Multiple Outcomes of Raloxifene Evaluation) randomized trial
    • Barrett-Connor E, Grady D, Sashegyi A, Anderson PW, Cox DA, Hoszowski K, et al. Raloxifene and cardiovascular events in osteoporotic postmenopausal women: four-year results from the MORE (Multiple Outcomes of Raloxifene Evaluation) randomized trial. JAMA 2002;287:847-57
    • (2002) JAMA , vol.287 , pp. 847-857
    • Barrett-Connor, E.1    Grady, D.2    Sashegyi, A.3    Anderson, P.W.4    Cox, D.A.5    Hoszowski, K.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.